TSS
OCUL icon

Two Sigma Securities’s Ocular Therapeutix OCUL Stock Holding History

Two Sigma Securities’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$140K Buy
+16,563
New +$158K 0.02% 1118
2025
Q4 		– Sell
-17,088
Closed -$200K – 1858
2025
Q3 		$200K Sell
17,088
-6,143
-26% -$73.5K 0.03% 820
2025
Q2 		$216K Buy
+23,231
New +$182K 0.03% 878
2018
Q1 		– Sell
-10,970
Closed -$49K – 2871
2017
Q4 		$49K Buy
+10,970
New +$56K ﹤0.01% 1531

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Two Sigma Securities's OCUL Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Ocular Therapeutix (OCUL) in Q1 2026: 16,563 shares worth $140K. The stake represents 0.02% of the portfolio and ranks #1118 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in OCUL as recently as Q3 2025.

Two Sigma Securities first reported a position in OCUL in Q4 2017 and has held it in 4 quarters since. The position peaked at $216K in Q2 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Two Sigma Securities held 16,563 shares of Ocular Therapeutix worth $140K as of Q1 2026.
  • Ocular Therapeutix was a new Two Sigma Securities position in Q1 2026.
  • Ocular Therapeutix made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1118 holding.
  • Two Sigma Securities first reported a position in Ocular Therapeutix in Q4 2017 and has held it in 4 quarters since.
  • Two Sigma Securities's Ocular Therapeutix position peaked at $216K in Q2 2025.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.